文献速递遗传性与小管间质肾病

前列腺素类似物与Eupatilin作为肾单位肾痨的治疗方法

Prostaglandin Analogs and Eupatilin as Treatments for Nephronophthisis.
PubMed 文献 · Kidney Int Rep · 2025-05-02

本研究在NPHP1和IQCB1/NPHP5患者肾细胞及nphp斑马鱼模型中评估前列腺素类似物、ROCK抑制剂和Eupatilin的疗效。Eupatilin部分挽救NPHP1相关纤毛发生缺陷并抑制细胞周期进程;前列腺素类似物和Eupatilin均挽救NPHP5患者细胞纤毛缺陷,但仅前列腺素类似物减小斑马鱼前肾囊肿。

要点

  • Eupatilin部分挽救NPHP1患者肾细胞的纤毛发生缺陷。
  • 前列腺素类似物和Eupatilin均挽救NPHP5患者细胞的纤毛缺陷。
  • 仅前列腺素类似物减小nphp斑马鱼模型的前肾囊肿大小。

核心结论

  • 这些分子可在不同遗传背景下显示有益效应,并揭示其作为肾单位肾痨治疗干预的潜力。

研究设计与样本

  • 采用表型筛选方法在培养细胞系中先前鉴定前列腺素类似物为候选治疗分子。
  • 本研究在NPHP1和IQCB1/NPHP5患者肾细胞及nphp斑马鱼突变系(traf3ip1/ift54)中研究ROCK抑制剂和Eupatilin的潜在有益效应。

主要发现

  • Eupatilin部分挽救NPHP1相关纤毛发生缺陷。
  • 转录组分析指出Eupatilin抑制细胞周期进程,可能解释其对纤毛组装的广泛效应。
  • NPHP5患者细胞中观察到的纤毛缺陷被前列腺素和Eupatilin均挽救。
  • 仅前列腺素类似物能够减小所用nphp斑马鱼模型的前肾囊肿大小。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Primary cilia (PCs) are sensory antennae that are present on the majority of quiescent vertebrate cells where they mediate key signaling during development and in response to environmental stimuli. Defects in PCs result in a group of heterogeneous inherited disorders with overlapping phenotypes, called ciliopathies. Nephronophthisis is an autosomal recessive tubulointerstitial kidney ciliopathy with > 25 identified genes called NPHP. Presently, no treatment exists beyond supportive care and kidney transplant, underscoring the need for novel therapies. METHODS: Using a phenotypic screening approach in cultured cell lines, we previously identified prostaglandin analogues as candidate therapeutic molecules based on their ability to rescue ciliogenesis defects in kidney tubular cells from patients with NPHP1 . Here, we investigated the potential beneficial effects of ROCK inhibitor and Eupatilin, similarly identified by other groups in different NPHP contexts, in kidney cells from patients with NPHP1 and those with IQCB1/NPHP5 as well as in a zebrafish nphp mutant line (traf3ip1/ift54). RESULTS: Eupatilin partially rescued NPHP1-associated ciliogenesis defects. Transcriptomic analyses pointed out that cell cycle progression was inhibited by Eupatilin, likely explaining its broad effects on cilia assembly. Interestingly, though ciliary defects also observed in NPHP5 patient cells were rescued by both prostaglandins and Eupatilin, only prostaglandin analogues were able to reduce pronephric cysts size in the used nphp zebrafish model. CONCLUSION: Our study indicates that these molecules can show beneficial effects across genetic contexts and shed light on their potential as therapeutic interventions for nephronophthisis.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Tata A, Rocha G, Hureaux M, et al. Prostaglandin Analogs and Eupatilin as Treatments for Nephronophthisis. Kidney Int Rep. 2025. PMID: 40814642. doi:10.1016/j.ekir.2025.04.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。